Subsequent genetic alterations contribute to tumorigenesis such as the activation of proto-oncogene K-RAS (Kristen-ras) (40% of CRC) and the loss of the tumour suppressor TP53 (Tumor protein 53) (70% of CRC) [3]. This evidence concerns the gene TP53 and colorectal carcinoma.